Last update 03 Nov 2025

Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)

Overview

Basic Info

Drug Type
Prophylactic vaccine, Genetically engineered subunit vaccine
Synonyms
LYB-004
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious Diseases
Active Indication
Herpes Zoster
Inactive Indication-
Originator Organization
Guangzhou Patronus Biotech Co., Ltd.
Active Organization
Guangzhou Patronus Biotech Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
CTR20254120
/ RecruitingPhase 2
评价重组带状疱疹疫苗（CHO细胞）在40周岁及以上人群中接种的免疫原性和安全性的随机、盲法、平行对照的Ⅱ期临床试验
[Translation] A randomized, blinded, parallel-controlled phase II clinical trial to evaluate the immunogenicity and safety of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
NCT06874842
/ RecruitingPhase 1
A Phase I, Randomized, Observer-blinded, Parallel-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
NCT06335849
/ Active, not recruitingPhase 1
A Phase I, Randomized, Observer-blinded, Positive-Controlled, Dose Escalation Clinical Trial to Assess the Safety and Immunogenicity of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years
100 Clinical Results associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
Login to view more data
100 Translational Medicine associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
Login to view more data
100 Patents (Medical) associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
Login to view more data
100 Deals associated with Recombinant Zoster Vaccine(CHO Cell)(Patronus Biotech)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Herpes ZosterPhase 2
China
Guangzhou Patronus Biotech Co., Ltd.
23 Oct 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free